These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16054540)

  • 1. Initiation, dose reduction, and duration of inhaled corticosteroid therapy.
    O'Byrne PM
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):511-21, vi. PubMed ID: 16054540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction.
    Khor YH; Feltis BN; Reid DW; Ward C; Johns DP; Wood-Baker R; Walters EH
    Clin Exp Allergy; 2007 Aug; 37(8):1189-98. PubMed ID: 17651149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio E; Palumbo G; D'Orazio N
    Clin Ter; 2007; 158(4):363-70. PubMed ID: 17953289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disease duration on dose-response of inhaled budesonide in asthma.
    Selroos O
    Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mild asthma.
    Raghupathy A; Brashier B; Salvi S
    N Engl J Med; 2005 Jul; 353(4):424-7; author reply 424-7. PubMed ID: 16050057
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of mild asthma.
    Jenkins CR; Marks GB; Reddel HK
    N Engl J Med; 2005 Jul; 353(4):424-7; author reply 424-7. PubMed ID: 16050058
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled steroids and airway remodelling in asthma.
    Chetta A; Marangio E; Olivieri D
    Acta Biomed; 2003 Dec; 74(3):121-5. PubMed ID: 15055015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of mild asthma.
    Lee DK
    N Engl J Med; 2005 Jul; 353(4):424-7; author reply 424-7. PubMed ID: 16050056
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of nebulized sodium cromoglycate on adult patients with severe refractory asthma.
    Sano Y; Adachi M; Kiuchi T; Miyamoto T
    Respir Med; 2006 Mar; 100(3):420-33. PubMed ID: 16095893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal asthma: physiologic determinants and current therapeutic approaches.
    D'Alonzo GE; Ciccolella DE
    Curr Opin Pulm Med; 1996 Jan; 2(1):48-59. PubMed ID: 9363115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
    Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
    J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of symptom recurrence after low-dose inhaled corticosteroid cessation in mild persistent asthma.
    Tonelli M; Bacci E; Dente FL; Bartoli ML; Cianchetti S; Di Franco A; Vagaggini B; Zingoni M; Paggiaro PL
    Respir Med; 2006 Apr; 100(4):622-9. PubMed ID: 16253493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroid dose reduction in childhood asthma: is nitrosopnea informative?
    Gaston B
    Am J Respir Crit Care Med; 2005 May; 171(10):1065-6. PubMed ID: 15879424
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled corticosteroids in obstructive airway disease.
    Phua GC; Macintyre NR
    Respir Care; 2007 Jul; 52(7):852-8. PubMed ID: 17594729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
    Ernst P; Franssen E; Chan CK; Okell M; O'Byrne P; Bai T
    Respir Med; 2008 Jan; 102(1):77-81. PubMed ID: 17904834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
    ten Hacken NH; Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.